ReviewDiabetology & metabolic syndrome2023

Efficacy and safety of tirzepatide, dual GLP-1/GIP receptor agonists, in the management of type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials.

Qian Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.